Impact BioMedical, Book Value Per Share vs. Shares Owned By Insiders
| IBO Stock | USD 1.80 0.05 2.70% |
Book Value Per Share | First Reported 2010-12-31 | Previous Quarter 0.0244 | Current Value 0.0224 | Quarterly Volatility 0.0056841 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.37 | 0.42 |
|
|
For Impact BioMedical, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Impact BioMedical, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Impact BioMedical, utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Impact BioMedical,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Impact BioMedical, over time as well as its relative position and ranking within its peers.
Impact |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Impact BioMedical, Shares Owned By Insiders vs. Book Value Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Impact BioMedical,'s current stock value. Our valuation model uses many indicators to compare Impact BioMedical, value to that of its competitors to determine the firm's financial worth. Impact BioMedical, is currently regarded as number one stock in book value per share category among its peers. It also is currently regarded as number one stock in shares owned by insiders category among its peers making about 20.28 of Shares Owned By Insiders per Book Value Per Share. At this time, Impact BioMedical,'s Book Value Per Share is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Impact BioMedical,'s earnings, one of the primary drivers of an investment's value.Impact Shares Owned By Insiders vs. Book Value Per Share
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Impact BioMedical, |
| = | 2.72 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Impact BioMedical, |
| = | 55.16 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Impact Shares Owned By Insiders Comparison
Impact BioMedical, is currently under evaluation in shares owned by insiders category among its peers.
Impact BioMedical, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Impact BioMedical,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Impact BioMedical, will eventually generate negative long term returns. The profitability progress is the general direction of Impact BioMedical,'s change in net profit over the period of time. It can combine multiple indicators of Impact BioMedical,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -3.6 M | -3.8 M | |
| Net Loss | -4 M | -4.2 M | |
| Income Before Tax | -4 M | -4.2 M | |
| Total Other Income Expense Net | 59.8 K | 62.8 K | |
| Net Loss | -3.9 M | -4.1 M | |
| Net Interest Income | -495.6 K | -520.4 K | |
| Interest Income | 11.7 K | 16.3 K | |
| Net Loss | (0.06) | (0.06) | |
| Income Quality | 0.47 | 0.84 |
Impact Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Impact BioMedical,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Impact BioMedical, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Impact BioMedical,'s important profitability drivers and their relationship over time.
Use Impact BioMedical, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Impact BioMedical, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Impact BioMedical, will appreciate offsetting losses from the drop in the long position's value.Impact BioMedical, Pair Trading
Impact BioMedical, Pair Trading Analysis
The ability to find closely correlated positions to Impact BioMedical, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Impact BioMedical, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Impact BioMedical, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Impact BioMedical, to buy it.
The correlation of Impact BioMedical, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Impact BioMedical, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Impact BioMedical, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Impact BioMedical, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Impact BioMedical, position
In addition to having Impact BioMedical, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Shipping Containers Thematic Idea Now
Shipping Containers
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipping Containers theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipping Containers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
To fully project Impact BioMedical,'s future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Impact BioMedical, at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Impact BioMedical,'s income statement, its balance sheet, and the statement of cash flows.